Browsing: David

BioCryst Pharmaceuticals has appointed David W. Jenkins, Ph.D., as its first chief scientific officer, a newly created executive role designed to strengthen the company’s research strategy as it expands its rare disease pipeline through external innovation and partnerships. The appointment is effective immediately, with Jenkins reporting to Chief Research and Development Officer Dr. Sandeep Menon…

In lead-up to the launch of a new Special Olympics initiative, SO-Link (Linking Athletes with Scientific Opportunities), I met with Special Olympics Virginia athlete David Egan to talk about the importance of including people with intellectual and developmental disabilities (IDD) in research